| Product NDC: | 0049-2340 |
| Proprietary Name: | Relpax |
| Non Proprietary Name: | ELETRIPTAN HYDROBROMIDE |
| Active Ingredient(s): | 40 mg/1 & nbsp; ELETRIPTAN HYDROBROMIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0049-2340 |
| Labeler Name: | Roerig |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021016 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20021226 |
| Package NDC: | 0049-2340-45 |
| Package Description: | 6 TABLET, FILM COATED in 1 BLISTER PACK (0049-2340-45) |
| NDC Code | 0049-2340-45 |
| Proprietary Name | Relpax |
| Package Description | 6 TABLET, FILM COATED in 1 BLISTER PACK (0049-2340-45) |
| Product NDC | 0049-2340 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ELETRIPTAN HYDROBROMIDE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20021226 |
| Marketing Category Name | NDA |
| Labeler Name | Roerig |
| Substance Name | ELETRIPTAN HYDROBROMIDE |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |